Grano v. Sodexo, Inc.

CourtDistrict Court, S.D. California
DecidedOctober 12, 2021
Docket3:18-cv-01818
StatusUnknown

This text of Grano v. Sodexo, Inc. (Grano v. Sodexo, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grano v. Sodexo, Inc., (S.D. Cal. 2021).

Opinion

1 2 3 UNITED STATES DISTRICT COURT 4 SOUTHERN DISTRICT OF CALIFORNIA 5 Case Nos.: 18cv1818-TWR(BLM) 6 VINCENT GRANO, et al.,

7 Plaintiffs, ORDER GRANTING IN PART AND DENYING IN PART CARGILL’S MOTION 8 v. TO COMPEL

9 SODEXO MANAGEMENT, INC., et al., [ECF Nos. 375, 377] 10 Defendants. 11 ____________________________________ 12 AND RELATED CASES 13 14 Currently before the Court are letter briefs dated September 29, 2021, from Plaintiffs and 15 Defendant Cargill Meat Solutions Corp. ECF Nos. 377 (“Pl.s’ Mot.”), 375 (“Cargill Mot.”). For 16 the reasons set forth below, Cargill’s request to compel further response from Plaintiffs is 17 GRANTED IN PART AND DENIED IN PART. 18 RELEVANT BACKGROUND 19 On July 19, 2021, Cargill filed a motion in limine to exclude a preliminary CDC report and 20 a related case-control study. ECF No. 337. Plaintiffs opposed the motion on September 21, 21 2021. ECF No. 364. The exhibits to the opposition include declarations from Amelia Keaton, 22 M.D., Medical Officer at the CDC, who was part of the 2017 CDC outbreak investigation and co- 23 authored the preliminary CDC trip report [see ECF No. 364-2] and Captain Jennifer Espiritu, a 24 Navy physician who assisted the CDC with its 2017 outbreak investigation [see ECF No. 364-5]. 25 Cargill Mot. at 2-3. The declarations provide additional information about the investigations of 26 the outbreak and their involvement in those investigations. Id.; see also ECF No. 377-2. 27 On December 18, 2020, Cargill served Plaintiffs with its First Set of Interrogatories and 1 You received or obtained related to this litigation in response to Your requests to third parties, 2 whether via subpoena, Freedom of Information Request, letter request, or any other formal or 3 informal request” and “REQUEST NO. 4: All documents and communications related to any 4 governmental or private organization’s investigation into the source of the E. coli Outbreak.” 5 Cargill’s Mot. at 3; see also ECF No. 377-3 at 1. Plaintiffs responded to the requests and later 6 supplemented those responses. Cargill’s Mot. at 3-4. On September 22, 2021, Cargill wrote to 7 Plaintiffs’ counsel and requested that they further supplement their responses to RFP Nos. 3 and 8 4 with underlying communications related to the declarations obtained from Drs. Keaton and 9 Espiritu. Id. at 4. Plaintiffs declined to do so and after meeting and conferring on the issue the 10 parties were unable to come to a resolution. 11 On September 24, 2021, counsel for Defendant Cargill, Mr. Bylund and Ms. Akalaonu, and 12 counsel for Plaintiffs, Mr. Falkenstein, jointly contacted the Court regarding this discovery 13 dispute. ECF No. 371. That same day, the Court ordered the parties to file letter briefs not to 14 exceed ten (10) pages in length by close of business on September 29, 2021. Id. The parties 15 timely filed their briefs in accordance with the Court’s order. Pl.s’ Mot., Cargill Mot. 16 LEGAL STANDARD 17 The scope of discovery under the Federal Rules of Civil Procedure is defined as follows:

18 Parties may obtain discovery regarding any nonprivileged matter that is relevant 19 to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in 20 controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether 21 the burden or expense of the proposed discovery outweighs its likely benefit. 22 Information within this scope of discovery need not be admissible in evidence to be discoverable. 23 24 Fed. R. Civ. P. 26(b)(1). District courts have broad discretion to determine relevancy for 25 discovery purposes. See Hallett v. Morgan, 296 F.3d 732, 751 (9th Cir. 2002). District courts 26 also have broad discretion to limit discovery to prevent its abuse. See Fed. R. Civ. P. 26(b)(2) 27 (instructing that courts must limit discovery where the party seeking the discovery “has had 1 discovery is “unreasonably cumulative or duplicative,” “obtain[able] from some other source that 2 is more convenient, less burdensome, or less expensive,” or where it “is outside the scope 3 permitted by Rule 26(b)(1)”). 4 CARGILL’S POSITION 5 Cargill seeks an order from the Court requiring Plaintiffs to supplement their production 6 of documents. Cargill Mot. at 1. Specifically, Cargill seeks 7 1) Plaintiffs’ written emails, requests, and correspondence to the CDC and to the 8 Navy seeking testimony and declarations from Keaton and Espiritu, as well as the written responses they received from these agencies as to those requests; 9 2) All emails, correspondence, and written communications between Plaintiffs’ 10 counsel and the CDC, the Navy, Keaton, and/or Espiritu related to the drafting, 11 revising, editing, finalizing, and signing of the Keaton declaration and the Espiritu 12 declaration including any drafts, notes, comments, etc.; 13 3) Plaintiffs’ emails and written correspondence (this includes Plaintiffs’ counsel and Plaintiffs’ representatives, including any of their experts, which includes Dr. 14 Kirk Smith) with the CDC, including the Office of General Counsel, the Director 15 (or her representative), and Dr. Keaton related to this litigation, and 16 4) Plaintiffs’ emails and written correspondence (this includes Plaintiffs’ counsel 17 and Plaintiffs’ representatives, including any of their experts) with the Navy, including with Rob Anselm (Legal Counsel – Naval Medical Forces Atlantic), 18 Office of the Judge Advocate General, the General Litigation Division (including 19 with Ann T. Oakes, Nathaniel A. Bosiak, and/or Virginia Hinton, the Director of the 20 General Litigation Division (or his representative), and Captain Espiritu. 21 Id. at 10. 22 Cargill argues that Plaintiffs’ underlying communications with the CDC and the Navy are 23 subject to the Freedom of Information Act (“FOIA”) and are not protected by the attorney work- 24 product doctrine. Id. at 5. Cargill also argues that even if attorney work-product applied, it has 25 been waived. Id. at 6-7. Finally, Cargill argues that it has a substantial need for the underlying 26 communications and cannot obtain the communications by other means without undue 27 hardship. Id. at 7-8. 1 PLAINTIFFS’ POSITION 2 Plaintiffs contend that the information Cargill seeks is not responsive to the overbroad 3 requests contained in RFP Nos. 3 and 4. Pl.s’ Mot. at 3-4. Plaintiffs further contend that (1) the 4 materials Cargill seeks “are squarely within the work-product privilege[;]” (2) Cargill has not 5 established the requisite need to overcome the privilege since Cargill has the same access to 6 the information and witnesses; (3) the requested information is not relevant to the pending 7 litigation; and (4) Drs. Keaton and Espiritu’s status as federal employees does not change the 8 analysis. Id. at 4-9. Plaintiffs also note that they have not sought and received the same 9 information from Cargill, and they are not attempting to delay the case to prevent Cargill from 10 using the requested materials in their reply briefs on the pending dispositive motions Id. 11 DISCUSSION 12 A. Applicable Law 13 As an initial matter, the parties disagree about whether California state law or Federal 14 law governs this dispute. Cargill argues that “[g]iven that issues concerning the work-product 15 doctrine are procedural, the discovery dispute here is governed by the Federal Rule of Civil 16 Procedure 26(b)(3).” Cargill Mot. at 6 (citing Great Am. Assur. Co. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Nobles
422 U.S. 225 (Supreme Court, 1975)
Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
Hallett v. Morgan
296 F.3d 732 (Ninth Circuit, 2002)
Farouki v. PETRA INTERNATIONAL BANKING, CORP.
683 F. Supp. 2d 23 (District of Columbia, 2010)
Great American Assurance Co. v. Liberty Surplus Insurance
669 F. Supp. 2d 1084 (N.D. California, 2009)
United States v. Sanmina Corporation
968 F.3d 1107 (Ninth Circuit, 2020)
Towne Place Condo. Ass'n v. Phila. Indem. Ins. Co.
284 F. Supp. 3d 889 (E.D. Illinois, 2018)
Cobell v. Norton
212 F.R.D. 14 (District of Columbia, 2002)
Ideal Electric Co. v. Flowserve Corp.
230 F.R.D. 603 (D. Nevada, 2005)
Randleman v. Fidelity National Title Insurance
251 F.R.D. 281 (N.D. Ohio, 2008)
Securities & Exchange Commission v. Roberts
254 F.R.D. 371 (N.D. California, 2008)
Bozzuto v. Cox, Castle & Nicholson LLP
255 F.R.D. 673 (C.D. California, 2009)
Gerber v. Down East Community Hospital
266 F.R.D. 29 (D. Maine, 2010)
United States v. Fishman
15 F.R.D. 124 (S.D. New York, 1952)
Griffith v. Davis
161 F.R.D. 687 (C.D. California, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Grano v. Sodexo, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/grano-v-sodexo-inc-casd-2021.